FDMT vs WDAY · rev $37.0K vs P/E 135, rev $8.45B
4D Molecular Therapeutics Inc (FDMT) versus Workday Inc (WDAY) — a side-by-side from cached financials, not a winner call.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Workday Inc (WDAY) is a software - application company listed on US.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
Latest reported WDAY revenue for 2025-01-31 was $8.45B. Net income was $526.0M. Revenue was up 16.4% from 2024-01-31 to 2025-01-31. WDAY currently screens at market cap $64.45B and trailing P/E 135.1.
FDMT currently screens at market cap $518.1M. WDAY currently screens at market cap $64.45B and trailing P/E 135.1.
Not investment advice. Open the FDMT and WDAY stock pages for the full models.
Not investment advice.